Nowadays, most diseases are curable if detected in time. Modern medicine and technology have pooled their capacities and made it much easier for us to answer any questions we might have about our health. The early diagnostics is the key factor in treating many diseases. Today’s advanced technology makes it possible for such diagnostics to be more available and therefore more accessible to patients. Medical and technological innovation represents a major step forward in the detection and treatment of diseases.
We still have a lack of knowledge about pelvic floor diseases in women. For this particular reason, the diagnostics, but also education, are of essential importance in the prevention and treatment of this widespread disorder.
What Does Renovia Inc. Deals With?
The company Renovia Inc., which is headed by the CEO Marc Beer, has stepped forward with new products related to the pelvic floor disorder.
This medical-technological company from Boston deals with the development of diagnostics and diagnostic agents. These exact things are used for therapeutic purposes with pelvic floor and urinary incontinence diseases. Researchers claim that these types of diseases affect more than 250 million women all over the world.
Renovia’s Innovations And Its Investors
The first product that Renovia Inc. presented on the medical market is the Leva, which was officially approved by the FDA in April 2018.
Renovia Inc. has attracted plenty of investors, including The Longwood Fund. It is an investment company with a focus on health care. It was this company that invested in Renova, joining Perceptive Advisors from New York and Ascension Ventures from Missouri. Their funds will be directed to the testing and development of four diagnostic devices, including the new generation of Leva devices.
The management of Renovia Inc. and its CEO Marc Beer are more than satisfied with the support they received from the leading investors. They consider it a joint victory because they share the same vision of better health care and prevention. Their mutual view is that together they will improve the treatment and quality of life of a huge number of women suffering from pelvic floor disease and disorders.
Marc Beer’s Innovative Ideas
Renovia’s CEO, Marc Beer, recently spoke about combining innovative sensor technology with a digital health platform. This will give patients very valuable data and information about the possibilities of new treatments, medical procedure and general understanding of the pelvic floor disorder itself. Nevertheless, the company has not yet made a statement about investments and new product lines.
Marc Beer’s venture in Renovia started in 2015. Before that, he was well-known for his work in some other medical companies. CEO and co-founder of Renovia Inc brought with himself more than 25 years of his experience of developing in biotechnology, pharmacy, diagnostics, and medical devices. Marc Beer was one of the Renovia founders who closed a series of financing with leading capital funds. Learn more: https://www.bizjournals.com/boston/news/2018/08/21/ex-aegerion-chief-beer-raises-42m-for-womens.html